Guardant Health Inc (GH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access GH Annual Cash Flow →
Examining cash flow movements between Guardant Health Inc and Jun 30 2025 reveals how Jun 30 2026 allocates cash as operating conditions evolve.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
6 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-232.22
Depreciation & amortization19.00
Amortization of Other Assets-0.36
Increase (Decrease) in Deferred Revenue0.00
Other Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories19.59
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation105.33
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Unrealized Translations Losseson Obligation Relatedto Royalty-
Unrealized Translations Gain Loss On Obligation Related To Royalty-
Non Cash Operating Lease Costs8.56
Charge Of In Process Research And Development-
Increase Decrease In Operating Lease Liabilities-8.60
Equity Securities Fv Ni Unrealized Gain Loss-
Increase Decrease In Accounts Payable Accrued And Other Liabilities-8.23
Fair Value Adjustments Of Noncontrolling Interest Liability-
Increase Decrease In Contract With Customer Liability-3.23
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable5.94
Increase (Decrease) in Accounts Payable0.00
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets24.20
Other Working Capital-1.96
Other Noncash Income (Expense)0.22
Other net7.98
Payments for (Proceeds from) Other Operating Activities-71.13
Discontinued operations0.00
Net Cash flow from Operating Activities-123.40
Investing Activities
Capital Expenditures-17.34
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities1,068.17
Payments to Acquire Available-for-sale Securities, Debt-249.94
Real Estate Investments0.00
Payments In Connection With License Agreements-
Payments To Acquire Equity Securities F V N I-
Payments To Acquire Equity Securities Fv Ni-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities800.89
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.10
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock31.94
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-30.40
Other net0.00
Payment Relatedto Settlement of Debt and Buyout of Royalty Obligations-
Finance Lease Principal Payments-
Right Of Use Asset Obtained In Exchange For Operating Lease Liability-
Capital Expenditures Incurred But Not Yet Paid-
Property Plant And Equipment Acquired Under Finance Leases-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents489.42
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.44
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-140.74
Total Cash Flow678.32
4 historic quarters locked

Sign in to unlock the full Guardant Health Inc cash flow history.

About Guardant Health Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: July 30, 2026
  • Source: gh-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001576280-26-000037

Figures are derived from filed reports and may be restated. Historical data is subject to revision.